Bulletin
Investor Alert

Dare Bioscience Inc.

NAS: DARE

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Jul 1, 2022, 7:09 p.m.

/zigman2/quotes/203460984/composite

$

1.18

Change

-0.01 -0.84%

Volume

Volume 1,901

Quotes are delayed by 20 min

/zigman2/quotes/203460984/composite

Previous close

$ 1.23

$ 1.19

Change

-0.04 -3.25%

Day low

Day high

$1.18

$1.24

Open

52 week low

52 week high

$0.92

$2.51

Open

Company Description

Daré Bioscience, Inc. operates as a healthcare company, which engages in the development and commercialization of pharmaceutical products in women's reproductive health. Its products include Ovaprene and Topical Sildenafil. The company was founded by Sabrina Martucci Johnson, Lisa Walters-Hoffert an...

Daré Bioscience, Inc. operates as a healthcare company, which engages in the development and commercialization of pharmaceutical products in women's reproductive health. Its products include Ovaprene and Topical Sildenafil. The company was founded by Sabrina Martucci Johnson, Lisa Walters-Hoffert and Roger L. Hawley in 2015 and is headquartered in San Diego, CA.

Valuation

Price to Book Ratio

4.33

Enterprise Value to EBITDA

-1.27

Efficiency

Liquidity

Current Ratio

3.44

Quick Ratio

3.44

Cash Ratio

3.22

Profitability

Return on Assets

-122.15

Return on Equity

-205.82

Return on Total Capital

-202.27

Capital Structure

Total Debt to Total Assets

0.48

Officers and Executives

Name Age Officer Since Title
Ms. Sabrina Martucci Johnson 66 2015 President, CEO, Secretary & Director
Mr. Mark Walters 65 - Vice President-Projects & Operations
Ms. Lisa Walters-Hoffert 61 2015 Chief Financial & Business Officer
Dr. Christine Mauck - 2016 Medical Director
Dr. David Friend - 2018 Chief Scientific Officer

Insider Actions

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
04/11/2019 Roger L. Hawley
Director
454,545   Acquisition at $1.1 per share. 499,999
06/11/2018 Roger L. Hawley
Director
140,000   Acquisition at $1.45 per share. 203,000
07/19/2017 Roger L. Hawley
Director
307,714   Award at $0 per share. 0
07/19/2017 Roger L. Hawley
Director
182,697   Award at $0 per share. 0
07/19/2017 Sabrina Martucci Johnson
Chief Executive Officer; Director
962,062   Award at $0 per share. 0
07/19/2017 Lisa Walters-Hoffert
Chief Financial Officer
443,512   Award at $0 per share. 0
07/19/2017 Robin Joan Steele
Director
246,171   Award at $0 per share. 0
/news/latest/company/us/dare

MarketWatch News on DARE

  1. Daré Bioscience stock price target raised to $4 from $3 at Maxim Group

    8:46 a.m. Jan. 18, 2022

    - Tomi Kilgore

  2. Dare Biosciences rockets on Bayer licensing deal

    9:25 a.m. Jan. 13, 2020

    - MarketWatch.com

  3. Cerulean Pharma's stock plummets 64% premarket after jobs cuts and asset sales, stock purchase deal

    8:48 a.m. March 20, 2017

    - Tomi Kilgore

  4. Cerulean Pharma downgraded to market perform from outperform at Leerink Partners

    7:15 a.m. Aug. 18, 2016

    - Tomi Kilgore

  5. Cerulean Pharma started at overweight with $8 stock price target at Barclays

    8:42 a.m. Sept. 22, 2015

    - Tomi Kilgore

  6. Almost half of venture-backed IPOs this year are losers

    6:00 a.m. Oct. 3, 2014

    - Philip van Doorn

/news/nonmarketwatch/company/us/dare

Other News on DARE

  1. CLVS, TCOM and GTE among pre market gainers

    8:38 a.m. June 27, 2022

    - Seeking Alpha

  2. Daré Bioscience (DARE) Investor Presentation - Slideshow

    2:02 p.m. May 26, 2022

    - Seeking Alpha

  3. 10-Q: DARE BIOSCIENCE, INC.

    4:14 p.m. May 12, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  4. Notable earnings after Thursday's close

    5:35 p.m. May 11, 2022

    - Seeking Alpha

  5. 10-K: DARE BIOSCIENCE, INC.

    4:21 p.m. March 31, 2022

    - Edgar Online - (EDG = 10Q, 10K)

  6. SURF, FREY and CPSH among pre market gainers

    8:34 a.m. March 31, 2022

    - Seeking Alpha

  7. Organon in pact with Daré Bioscience for Xaciato

    8:16 a.m. March 31, 2022

    - Seeking Alpha

  8. Daré Bioscience (DARE) Investor Presentation -Slideshow

    2:44 p.m. March 22, 2022

    - Seeking Alpha

  9. Daré Bioscience (DARE) Investor Presentation - Slideshow

    3:03 p.m. Feb. 17, 2022

    - Seeking Alpha

  10. Diving Back Into Daré Bioscience Again

    5:29 p.m. Jan. 7, 2022

    - Seeking Alpha

  11. CRDF, ATER and LEXX among pre market gainers

    9:32 a.m. Dec. 8, 2021

    - Seeking Alpha

  12. Loading more headlines...

At a Glance

Daré Bioscience, Inc.

3655 Nobel Drive

Suite 260

San Diego, California 92122

Phone

1 8589267655

Industry

Biotechnology

Sector

Health Care/Life Sciences

Fiscal Year-end

12/2022

Revenue

N/A

Net Income

$-38.70M

Employees

28.00

/news/pressrelease/company/us/dare

Press Releases on DARE

  1. Good Penny Stocks to Buy Now? 3 to Watch in June

    3:36 p.m. June 2, 2022

    - Penny Stocks

  2. Dare Bioscience Announces NIH Grant Award

    8:00 a.m. May 11, 2022

    - GlobeNewswire

  3. Dare Bioscience to Participate in Upcoming Conference

    8:00 a.m. April 14, 2022

    - GlobeNewswire

  4. Dare Bioscience Initiates Phase 1/2 Clinical Study of DARE-HRT1

    8:00 a.m. April 12, 2022

    - GlobeNewswire

  5. Dare Bioscience to Participate in Upcoming Conferences

    9:00 a.m. March 2, 2022

    - GlobeNewswire

  6. Dare Bioscience to Participate in Upcoming Conferences

    9:00 a.m. Feb. 7, 2022

    - GlobeNewswire

  7. 4 Penny Stocks To Buy For Under $4 Right Now

    1:23 p.m. Jan. 19, 2022

    - Penny Stocks

  8. Loading more headlines...
Link to MarketWatch's Slice.